Bifidobacterium lactis – MB2409 (DSM 23733)

    Cardiology strain | Cholesterol management

    Characteristics

    FUNCTIONALITY
    Cardiovascular health • Cholesterol lowering

    Scientific support

    In vitro and in vivo testing
    Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.


    Cardiology blend | Cholesterol management

    • Bifidobacterium lactis – MB2409 (DSM 23733)
    • Bifidobacterium bifidum – MB109 (DSM 23731)
    • Bifidobacterium longum – 04 (DSM 23233)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    1 billion CFU/strain

    FUNCTIONALITY
    Cardiovascular health • Cholesterol lowering

    Scientific support

    Human clinical trial
    Guardamagna O. et al. Bifidobacteria supplementation: effects on plasma lipid profile in dyslipidemic children. Nutrition (2014), doi: 10.1016/ j.nut. 2014.01.014.

    In vitro and in vivo testing
    Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.